New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone Disorder

NCT03307707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2017-10-12

No results posted yet for this study

Summary

the objective of this study is to :

-Determinate wether the circulating levels of iFGF23 and klotho can be a predictor biomarker of HF in patients with CKD-MBD.

Conditions

Sponsors & Collaborators

  • Pr. Semir Nouira

    lead OTHER

Principal Investigators

  • Lamti Feten, PhD student · Research Laboratory (LR12SP18) University of Monastir Tunisia, Tunisia and Research Unit (UR17ES29) Faculty of Pharmacy , Monastir

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-15
Primary Completion
2015-09-30
Completion
2015-12-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03307707 on ClinicalTrials.gov